首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1626519

輸液幫浦市場：按應用、最終用戶、地區、範圍和預測，2024 年至 2031 年

Infusion Pump Market By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology), By End-User (Hospitals, Home Care Settings, Ambulatory Care Settings), By Geographic Scope And Forecast & Region for 2024-2031

出版日期: 2024年09月22日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

輸液幫浦市場評估，2024 年至 2031 年

由於對能夠精確且可控地向患者輸液、輸送藥物和營養的創新醫療設備的需求不斷增加，輸液幫浦市場正在蓬勃發展。這些幫浦在醫院和家庭護理環境中必不可少，特別是對於需要持續輸液治療（例如疼痛管理、化療和胰島素治療）的患者。因此，輸液幫浦的需求預計將飆升，到 2024 年市場規模將超過 151.2 億美元，到 2031 年將達到 240.9 億美元的估值。

提高安全性和連接性的智慧幫浦等技術改進有助於提高接受度。由於慢性病的流行和老年人口的不斷增長進一步推動了對輸液泵的需求，預計市場將繼續增長。因此，由於遠端連接越來越受歡迎，市場將從 2024 年到 2031 年以 6.00% 的複合年增長率成長。

輸液幫浦市場定義/概述

輸液幫浦是一種以可控方式將藥物、營養物質或血液等液體輸送到患者體內的醫療設備。這些幫浦廣泛應用於醫院、診所和家庭護理環境，對於化療、疼痛管理和靜脈營養等治療至關重要，因為它們可以確保在規定的時間內精確的液體輸送率。

輸液幫浦廣泛用於給患者註射補充劑和藥物，如胰島素、荷爾蒙、抗生素、化療藥物和止痛藥。這些設備比手動輸液有幾個優點，包括能夠以精確編程的速率和自動間隔輸注極少量的液體。印度和中國等新興市場以及專用幫浦的日益普及，為輸液幫浦市場參與者帶來了巨大的成長機會。

慢性病的增加將如何推動輸液幫浦市場的成長？

老年族群中慢性病的發生率不斷上升，對輸液幫浦的需求也隨之增加。隨著年齡的增長，人們更容易患上糖尿病、心血管疾病和癌症等疾病，並且往往需要長期藥物治療。輸液幫浦提供了一種有效且精確的方法來輸送這些藥物，從而可以更好地管理慢性疾病。這對於治療方案複雜或需要多種藥物的老年患者尤其重要，因為輸液幫浦可以編程為在特定時間間隔輸送精確的劑量。

此外，向家庭醫療保健的轉變以及改善老年人生活品質的願望正在推動對便攜式和易於使用的輸液泵的需求。許多老年人更願意在自己舒適的家中接受治療，而不是去醫院。輸液幫浦技術的進步使得這些設備更加緊湊、更容易使用且適合家庭護理。這一趨勢不僅提高了患者的舒適度和獨立性，而且還有助於降低長期住院相關的醫療費用，使得輸液泵成為老年人護理中越來越重要的一部分。

競爭性定價在醫療機構採用輸液幫浦方面將扮演什麼角色？

預算限制和成本效益考量嚴重影響醫療設備（包括輸液幫浦）的購買決策。醫療保健提供者面臨著在保持高品質護理的同時控製成本的壓力，其中輸液幫浦的價格範圍是一個關鍵因素。價格具有競爭力且性能可靠、具備基本功能的泵浦更有可能被採用，尤其是在較小的醫療機構和資源受限的環境中。這樣的定價策略使得醫療機構無需增加預算就能獲得所需的設備，從而釋放資源用於其他重要的病患照護領域。

此外，擁有和維護輸液幫浦的長期成本也會影響採用率。醫療機構不僅考慮初始購買價格，還考慮維護、維修和消耗品等持續成本。提供具有價格競爭力的泵浦的製造商通常會提供具有成本效益的服務計劃、替換零件和相容的消耗品。這種綜合定價方法可以促進長期預算規劃並可能降低總擁有成本，從而使某些輸液泵型號對醫療機構更具吸引力。因此，解決初始成本和長期成本的競爭性定價策略可以顯著推動輸液幫浦在各種醫療保健環境中的採用。

概述
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 其他亞太地區
拉丁美洲
- 巴西
- 阿根廷
- 其他洛杉磯
中東和非洲
- 阿拉伯聯合大公國
- 沙烏地阿拉伯
- 南非
- 其他中東和非洲地區

第 8 章全球輸液幫浦市場：競爭格局

概述
各公司的市場排名
主要發展策略
公司的地理分佈
公司產業足跡
ACE 矩陣

第九章公司簡介

Becton, Dickinson and Company
Roche Diagnostics
B. Braun Melsungen
Baxter International
Fresenius Kabi
ICU Medical
Medtronic
Moog Inc.
Smiths Medical
Terumo Corporation
Roche Diagnostics

第 10 章附錄

相關研究
重大進展

簡介目錄

Product Code: 26268

Infusion Pump Market Valuation - 2024-2031

The infusion pump market is expanding rapidly due to increased demand for innovative medical equipment that enables precise and controlled delivery of fluids, drugs, and nutrition to patients. These pumps are vital in hospitals and home care settings, particularly for patients who need continuous infusion treatments such as pain management, chemotherapy, and insulin therapy. Thus, the growing demand for infusion pumps surged the growth of market size surpassing USD 15.12 Billion in 2024 to reach a valuation of USD 24.09 Billion by 2031.

Technological improvements, such as smart pumps with improved safety and connection, are boosting their acceptance. The increasing prevalence of chronic diseases, combined with the growing older population, is further fueling the demand for infusion pumps, positioning the market for continued growth. Thus, the growing popularity of remote connectivity enables the market to grow at a CAGR of 6.00% from 2024 to 2031.

Infusion Pump Market: Definition/ Overview

An infusion pump is a medical device that supplies fluids, such as drugs, nutrients, or blood, to a patient's body in a controlled manner. These pumps are widely utilized in hospitals, clinics, and home care settings, where they ensure accurate delivery rates over a predetermined period, making them critical for treatments such as chemotherapy, pain management, and intravenous feeding.

Infusion pumps are widely used to administer supplements or medications to patients, such as insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer several advantages over manual fluid administration, including the ability to deliver fluids in very small volumes at precisely programmed rates or at automated intervals. Emerging markets, such as India and China, present significant growth opportunities for players in the infusion pump market, alongside the increasing adoption of specialty pumps.

How Does the Increasing Prevalence of Chronic Diseases Surge the Growth of Infusion Pump Market?

The increased prevalence of chronic diseases among the elderly drives the need for infusion pumps. As people age, they become more susceptible to conditions such as diabetes, cardiovascular diseases, and cancer, which often require long-term medication administration. Infusion pumps provide an efficient and accurate method for delivering these medications, allowing for better management of chronic conditions. This is particularly crucial for elderly patients who may have complex treatment regimens or require multiple medications, as infusion pumps can be programmed to deliver precise dosages at specific intervals.

Furthermore, the shift towards home healthcare and the desire for improved quality of life among the elderly population boosts the demand for portable and user-friendly infusion pumps. Many older adults prefer to receive treatment in the comfort of their homes rather than in hospital settings. Advances in infusion pump technology have made these devices more compact, easier to use, and suitable for home care. This trend not only improves patient comfort and independence but also helps reduce healthcare costs associated with prolonged hospital stays, making infusion pumps an increasingly essential component of elderly care.

What Role Does Competitive Pricing Play in Influencing the Adoption of Infusion Pumps Among Healthcare Facilities?

Budget constraints and cost-effectiveness considerations significantly impact healthcare facilities' purchasing decisions for medical equipment, including infusion pumps. As healthcare providers face increasing pressure to manage costs while maintaining high-quality care, the price point of infusion pumps becomes a critical factor. Competitively priced pumps that offer reliable performance and essential features are more likely to be adopted, especially by smaller healthcare facilities or those in resource-constrained settings. This pricing strategy allows facilities to acquire necessary equipment without overstretching their budgets, enabling them to allocate resources to other critical areas of patient care.

Furthermore, the long-term cost implications associated with infusion pump ownership and maintenance also influence adoption rates. Healthcare facilities consider not only the initial purchase price but also ongoing expenses such as maintenance, repairs, and consumables. Manufacturers offering competitively priced pumps often provide cost-effective service plans, replacement parts, and compatible disposables. This comprehensive approach to pricing can make certain infusion pump models more attractive to healthcare facilities, as it allows for better long-term budget planning and potentially lower total cost of ownership. Consequently, competitive pricing strategies that address both upfront and long-term costs can significantly drive the adoption of infusion pumps across various healthcare settings.

Category-Wise Acumens

How does the Increasing Demand for Chemotherapy/Oncology Treatments Influence the Adoption of Infusion Pumps in Hospitals?

The chemotherapy/oncology segment dominates in the infusion pump market owing to the precision and safety requirements in chemotherapy administration drive the need for advanced infusion pumps. Chemotherapy drugs often require exact dosing and controlled delivery rates to maximize effectiveness while minimizing side effects. Modern infusion pumps offer programmable features that allow for precise control over drug delivery, including multi-step infusions and time-specific dosing schedules. This level of accuracy is crucial in oncology treatments, where even small variations in drug administration can impact treatment efficacy and patient safety. Consequently, hospitals are increasingly adopting smart infusion pumps with built-in safety features and drug libraries specific to oncology protocols.

The rise in outpatient and ambulatory cancer care services fuels the demand for portable and versatile infusion pumps. As more cancer treatments shift from inpatient to outpatient settings, hospitals require infusion pumps that can seamlessly transition between different care environments. Portable pumps allow patients to receive continuous treatment while maintaining mobility, improving their quality of life during lengthy chemotherapy regimens. This trend has led to increased adoption of lightweight, battery-operated infusion pumps that can be easily programmed for home use or monitored remotely by healthcare providers, enhancing the flexibility of cancer care delivery in hospital-affiliated outpatient clinics and home settings.

How does the Complex Drug Protocol and Need for Intricate Treatment Foster the Growth of Hospital Segment?

The hospital segment dominates the infusion pump market driven by the complexity of drug protocols and dosing regimens in hematology poses a major challenge. Hematological conditions often require intricate treatment plans involving multiple medications, precise dosing schedules, and frequent adjustments based on patient response. Integrating infusion pumps to accurately deliver these complex regimens demands sophisticated programming capabilities and seamless integration with electronic health records (EHR) systems. Hospitals must ensure that their infusion pumps can handle multi-step infusions, drug sequencing, and rapid protocol changes, which often necessitates investment in advanced smart pumps and extensive staff training to minimize errors and optimize treatment efficacy.

Furthermore, Compatibility issues with blood products and specialized hematology medications create another significant hurdle. Many hematology treatments involve the infusion of blood products, clotting factors, or highly viscous medications that may not be compatible with standard infusion pump settings. Hospitals must carefully select pumps that can handle these specialized products without compromising their integrity or causing equipment malfunction. Additionally, the risk of medication errors is heightened due to the critical nature of many hematology treatments. This requires hospitals to implement robust safety features, including barcode scanning, drug libraries specific to hematology, and alert systems to prevent potentially life-threatening mistakes during infusion therapy.

Country/Region-wise Acumens

What Impact do Regulatory Standards in North America have on the Development and Adoption of Infusion Pump Technologies?

North America substantially dominates the infusion pump market owing to the stringent safety and performance requirements set by regulatory bodies like the U.S. Food and Drug Administration (FDA) drive innovation in infusion pump design. These regulations mandate rigorous testing and validation processes to ensure pump reliability, accuracy, and safety. Manufacturers must demonstrate compliance with standards such as IEC 60601-1 for electrical safety and IEC 60601-2-24 for infusion pump performance. This regulatory environment pushes companies to invest heavily in research and development, resulting in advanced features like integrated drug libraries, dose error reduction systems, and interoperability capabilities. While these requirements can extend development timelines and increase costs, they ultimately lead to safer, more effective infusion pump technologies that healthcare providers can trust.

Furthermore, Regulatory oversight also influences the adoption rate of new infusion pump technologies in healthcare settings. The FDA's premarket approval (PMA) process for Class III medical devices, which includes many advanced infusion pumps, involves extensive clinical trials and data submission. This rigorous approval pathway can slow the introduction of novel technologies to the market. However, it also instills confidence among healthcare providers and patients, facilitating faster adoption once approval is granted. Additionally, regulatory bodies' post-market surveillance requirements, such as the FDA's adverse event reporting system, encourage ongoing improvements and updates to existing pump technologies. This continuous feedback loop between regulators, manufacturers, and end-users fosters a culture of constant innovation and refinement in the infusion pump industry.

How does the Healthcare Infrastructure in the Middle East & Africa Affect the Availability and Utilization of Infusion Pumps?

Asia Pacific is anticipated to witness the fastest growth in the infusion pump market driven by the disparities in healthcare development across the region creating a varied landscape for infusion pump adoption. In economically advanced areas, such as the Gulf Cooperation Council (GCC) countries, state-of-the-art medical facilities are equipped with modern infusion technologies, driving high utilization rates. These nations often have well-funded healthcare systems that can afford and maintain advanced infusion pumps. However, in less developed parts of Africa and conflict-affected areas of the Middle East, healthcare infrastructure is often underdeveloped or damaged. This leads to limited availability of infusion pumps, with many facilities relying on older, less sophisticated models or manual infusion methods. The stark contrast in resources affects not only the distribution of infusion pumps but also the types of pumps available in different areas.

Challenges in maintenance, training, and supply chain logistics significantly influence the utilization of infusion pumps. Many parts of the Middle East & Africa face difficulties in ensuring consistent power supply and maintaining sterile conditions, which are crucial for the proper functioning of infusion pumps. Additionally, there's often a shortage of trained healthcare professionals who can operate and maintain these devices effectively. Supply chain issues, including difficulties in importing replacement parts and consumables, can lead to prolonged periods of pump inactivity. These factors result in underutilization of available infusion pumps and reluctance among some healthcare providers to invest in more advanced models, despite their potential benefits. Consequently, efforts to improve infusion pump utilization in the region often focus not just on increasing availability, but also on enhancing infrastructure, training, and supply chain resilience.

Competitive Landscape

The Infusion Pump Market is highly competitive, characterized by rapid technological advancements, increasing demand for precision in drug delivery, and a focus on enhancing patient safety and regulatory compliance across healthcare settings.

Some of the prominent players operating in the infusion pump market include:

Becton

Dickinson, and Company

Braun Melsungen

Baxter International

Fresenius Kabi

ICU Medical

Medtronic

Moog Inc.

Smiths Medical

Terumo Corporation

Roche Diagnostics

Infusion Pump Market Latest Developments

In March 2024, Medtronic announced the launch of an AI-powered smart infusion system Medtronic introduced a new infusion pump with integrated artificial intelligence capabilities. The system uses machine learning algorithms to predict potential infusion errors and optimize drug delivery rates, significantly enhancing patient safety and treatment efficacy.

In January 2024, B. Braun expanded its infusion pump portfolio with the acquisition of B. Braun Melsungen AG a startup specializing in miniature infusion pump technology. This strategic move allows B. Braun to enter the wearable infusion pump market, targeting ambulatory care and home healthcare segments.

In November 2023, Baxter International announced the launch of a cybersecurity-enhanced pump Baxter a new line of infusion pumps with advanced cybersecurity features.

1 INTRODUCTION OF GLOBAL INFUSION PUMP MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

2.1 Data mining
2.2 Secondary research
2.3 Primary research
2.4 Subject matter expert advice
2.5 Quality check
2.6 Final review
2.7 Data Triangulation
2.8 Bottom-up approach
2.9 Top-down approach
2.10 Research flow
2.11 Data sources

3 EXECUTIVE SUMMARY

3.1 Overview
3.2 Absolute $ Opportunity
3.3 Market attractiveness
3.4 Future Market Opportunities

4 GLOBAL INFUSION PUMP MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL INFUSION PUMP MARKET, BY APPLICATION

5.1 Overview
5.2 Chemotherapy/Oncology
5.3 Diabetes
5.4 Gastroenterology
5.5 Analgesia/Pain Management
5.6 Pediatrics/Neonatology
5.7 Hematology
5.8 Other

6 GLOBAL INFUSION PUMP MARKET, BY END-USER

6.1 Overview
6.2 Hospitals
6.3 Home Care Settings
6.4 Ambulatory Care Settings
6.5 Academic & Research Institutes

7 GLOBAL INFUSION PUMP MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Argentina
- 7.5.3 Rest of LA
7.6 Middle East & Africa
- 7.6.1 UAE
- 7.6.2 Saudi Arabia
- 7.6.3 South Africa
- 7.6.4 Rest of MEA

8 GLOBAL INFUSION PUMP MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix

9 COMPANY PROFILES

9.1 Becton, Dickinson and Company
- 9.1.1 Company Overview
- 9.1.2 Company Insights
- 9.1.3 Business Breakdown
- 9.1.4 Product Benchmarking
- 9.1.5 Key Developments
- 9.1.6 Winning Imperatives
- 9.1.7 Current Focus & Strategies
- 9.1.8 Threat from Competition
- 9.1.9 SWOT Analysis
9.2 Roche Diagnostics
- 9.2.1 Company Overview
- 9.2.2 Company Insights
- 9.2.3 Business Breakdown
- 9.2.4 Product Benchmarking
- 9.2.5 Key Developments
- 9.2.6 Winning Imperatives
- 9.2.7 Current Focus & Strategies
- 9.2.8 Threat from Competition
- 9.2.9 SWOT Analysis
9.3 B. Braun Melsungen
- 9.3.1 Company Overview
- 9.3.2 Company Insights
- 9.3.3 Business Breakdown
- 9.3.4 Product Benchmarking
- 9.3.5 Key Developments
- 9.3.6 Winning Imperatives
- 9.3.7 Current Focus & Strategies
- 9.3.8 Threat from Competition
- 9.3.9 SWOT Analysis
9.4 Baxter International
- 9.4.1 Company Overview
- 9.4.2 Company Insights
- 9.4.3 Business Breakdown
- 9.4.4 Product Benchmarking
- 9.4.5 Key Developments
- 9.4.6 Winning Imperatives
- 9.4.7 Current Focus & Strategies
- 9.4.8 Threat from Competition
- 9.4.9 SWOT Analysis
9.5 Fresenius Kabi
- 9.5.1 Company Overview
- 9.5.2 Company Insights
- 9.5.3 Business Breakdown
- 9.5.4 Product Benchmarking
- 9.5.5 Key Developments
- 9.5.6 Winning Imperatives
- 9.5.7 Current Focus & Strategies
- 9.5.8 Threat from Competition
- 9.5.9 SWOT Analysis
9.6 ICU Medical
- 9.6.1 Company Overview
- 9.6.2 Company Insights
- 9.6.3 Business Breakdown
- 9.6.4 Product Benchmarking
- 9.6.5 Key Developments
- 9.6.6 Winning Imperatives
- 9.6.7 Current Focus & Strategies
- 9.6.8 Threat from Competition
- 9.6.9 SWOT Analysis
9.7 Medtronic
- 9.7.1 Company Overview
- 9.7.2 Company Insights
- 9.7.3 Business Breakdown
- 9.7.4 Product Benchmarking
- 9.7.5 Key Developments
- 9.7.6 Winning Imperatives
- 9.7.7 Current Focus & Strategies
- 9.7.8 Threat from Competition
- 9.7.9 SWOT Analysis
9.8 Moog Inc.
- 9.8.1 Company Overview
- 9.8.2 Company Insights
- 9.8.3 Business Breakdown
- 9.8.4 Product Benchmarking
- 9.8.5 Key Developments
- 9.8.6 Winning Imperatives
- 9.8.7 Current Focus & Strategies
- 9.8.8 Threat from Competition
- 9.8.9 SWOT Analysis
9.9 Smiths Medical
- 9.9.1 Company Overview
- 9.9.2 Company Insights
- 9.9.3 Business Breakdown
- 9.9.4 Product Benchmarking
- 9.9.5 Key Developments
- 9.9.6 Winning Imperatives
- 9.9.7 Current Focus & Strategies
- 9.9.8 Threat from Competition
- 9.9.9 SWOT Analysis
9.10 Terumo Corporation
- 9.10.1 Company Overview
- 9.10.2 Company Insights
- 9.10.3 Business Breakdown
- 9.10.4 Product Benchmarking
- 9.10.5 Key Developments
- 9.10.6 Winning Imperatives
- 9.10.7 Current Focus & Strategies
- 9.10.8 Threat from Competition
- 9.10.9 SWOT Analysis
9.11 Roche Diagnostics
- 9.11.1 Company Overview
- 9.11.2 Company Insights
- 9.11.3 Business Breakdown
- 9.11.4 Product Benchmarking
- 9.11.5 Key Developments
- 9.11.6 Winning Imperatives
- 9.11.7 Current Focus & Strategies
- 9.11.8 Threat from Competition
- 9.11.9 SWOT Analysis